SCHEMBL13738565

SCHEMBL13738565

COC(=O)c1ccc(C#CC#C[C@@H]2C[C@H]2COC(C)=O)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPN11 Q06124 1/20 0.39
▸ MAPT P10636 3/20 0.37
▸ ADORA3 P0DMS8 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ CASP1 P29466 1/20 0.35
▸ CASP7 P55210 1/20 0.35
▸ ATM Q13315 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ CYP3A4 P08684 2/20 0.35
▸ CYP2C19 P33261 2/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ CA1 P00915 2/20 0.34
▸ CA2 P00918 2/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ CA12 O43570 1/20 0.34
▸ CA7 P43166 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13740539 1.00 PTPN11 (0.39) PTPN11MAPTADORA3KDM4EALDH1A1
SCHEMBL13831242 0.92 PTPN11 (0.41) PTPN11MAPTADORA3KDM4EALDH1A1
SCHEMBL31303685 0.89 TSHR (0.42) PTPN11MAPTADORA3KDM4EALDH1A1
SCHEMBL16925442 0.88 RARB (0.37) PTPN11MAPTALDH1A1TSHRHSD17B10
SCHEMBL13832184 0.88 RARB (0.37) PTPN11MAPTALDH1A1TSHRHSD17B10
SCHEMBL16921534 0.85 PTPN11 (0.42) PTPN11MAPTKDM4EALDH1A1GAA
SCHEMBL16843162 0.79 PTPN11 (0.40) PTPN11MAPTCA1CA2TDP1
SCHEMBL16843129 0.78 PTPN11 (0.40) PTPN11MAPTKDM4EALDH1A1GAA
SCHEMBL16840436 0.78 PTPN11 (0.40) PTPN11MAPTKDM4EALDH1A1GAA
SCHEMBL16840420 0.78 PTPN11 (0.40) PTPN11MAPTKDM4EALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9701622-B2 Antibacterial agents ACHAOGEN, INC. (US) 2017-07-11 — — US disclosed
US-20160280639-A1 ANTIBACTERIAL AGENTS ACHAOGEN, INC. 2016-09-29 — — US disclosed
US-20150203444-A1 POLYMORPHS OF N-((S)-3-AMINO-1-(HYDROXYAMINO)-3-METHYL-1-OXOBUTAN-2-YL)-4-(((1R,2R)-2-(HYDROXYMETHYL)CYCLOPROPYL)BUTA-1,3-DIYNYL)BENZAMIDE ACHAOGEN, INC. (US) 2015-07-23 — — US disclosed
US-20150203444-A1 POLYMORPHS OF N-((S)-3-AMINO-1-(HYDROXYAMINO)-3-METHYL-1-OXOBUTAN-2-YL)-4-(((1R,2R)-2-(HYDROXYMETHYL)CYCLOPROPYL)BUTA-1,3-DIYNYL)BENZAMIDE ACHAOGEN, INC. (US) 2015-07-23 — — US disclosed
EP-2638006-A1 HYDROXAMIC ACID DERIVATIVES AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTIONS Achaogen, Inc. (US) 2013-09-18 — — EP disclosed
WO-2012154204-A1 HYDROXAMIC ACID DERIVATIVES AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTIONS ACHAOGEN, INC. (US) 2012-11-15 — — WO disclosed
WO-2012154204-A1 HYDROXAMIC ACID DERIVATIVES AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTIONS ACHAOGEN, INC. (US) 2012-11-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150203444-A1 POLYMORPHS OF N-((S)-3-AMINO-1-(HYDROXYAMINO)-3-METHYL-1-OXOBUTAN-2-YL)-4-(((1R,2R)-2-(HYDROXYMETHYL)CYCLOPROPYL)BUTA-1,3-DIYNYL)BENZAMIDE BBC3, HBG1, CYP1B1 PTPN11 3723/4885MAPT 3333/4885ADORA3 1251/4885
US-20160280639-A1 ANTIBACTERIAL AGENTS MRPL21, ABCB11, LSS PTPN11 3775/4885MAPT 4489/4885ADORA3 4399/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback